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 Abstract  12 
The terminal step in the biosynthesis of non-ribosomal peptides is the hydrolytic release, and 13 
frequently, macrocyclization of an aminoacyl-S-thioester by an embedded thioesterase. The 14 
surugamide biosynthetic pathway is composed of two NRPS assembly lines where one produces 15 
surugamide A, which is a cyclic octapeptide, and the other produces surugamide F, a linear 16 
decapeptide. The terminal module of each system lacks an embedded thioesterase, which led us to 17 
question how the peptides are released from the assembly line (and cyclized in the case of surugamide 18 
A). We characterized a cyclase belonging to the ȕ-lactamase superfamily (SurE) in vivo and 19 
established that it is a trans-acting release factor for both compounds and verified this functionality 20 
in vitro with a thioester mimic of linear surugamide A. Using bioinformatics, we estimate that ~11% 21 
of filamentous Actinobacteria harbor an NRPS system lacking an embedded thioesterase and instead 22 
employ a trans-acting cyclase. This study expands the paradigmatic understanding of how non-23 
ribosomal peptides are released from the terminal PCP and adds a new dimension to the synthetic 24 
biology toolkit.  25 
Non-ribosomal peptides (NRPs) are a large family of structurally complex and diverse natural 26 
products, often with biologically and therapeutically relevant activities. They are synthesized by large 27 
multifunctional enzymes called non-ribosomal peptide synthetases (NRPSs), which are organised 28 
into relatively independently functioning modules that work in an assembly line-like manner until the 29 
final polypeptide structure is generated.1 During biosynthesis, the growing peptide chain remains 30 
covalently linked to the 4´-phosphopantetheinyl cofactor of the peptidyl carrier protein (PCP) 31 
domains. The terminal module usually possesses a C-terminal thioesterase (TE) domain, which off-32 
loads the polypeptide intermediate from the PCP on to a conserved serine residue whereby either a 33 
hydrolytic or macrocylization reaction occurs to produce the mature peptide.2 34 
Surugamide A (1) and associated minor products B-E (2-5) are cyclic octapeptides initially 35 
identified from Streptomyces sp. JAMM992 as inhibitors of cathepsin B, which also possess 36 
antibacterial activity.3,4  Identification of the surugamide (sur) biosynthetic gene cluster (BGC) from 37 
this organism revealed the presence of four NRPS genes (surABCD), which encoded 18 biosynthetic 38 
modules (Figure 1, Scheme 1). The eight modules encoded by SurAD were consistent with the 39 
biosynthesis of 1-5, whereas the remaining 10 modules encoded by SurBC were shown to direct the 40 
biosynthesis of an unrelated linear decapeptide named, surugamide F (7), which is structurally similar 41 
to gramicidin A.5 S. albus J1074 was recently shown to produce surugamides, including an unusual 42 
derivative named acyl-surugamide A (6), which has antifungal bioactivity.6,7 We identified the same 43 
BGC in a related strain, S. albus S48 and verified that it produced the major products 1 and 7 using 44 
LC-HRMS (Figures S1-S5). An intriguing feature of the sur BGC harbored by these organisms is 45 
that the terminal biosynthetic modules of SurC and SurD lack an integrated thioesterase domain and 46 
alternative off-loading mechanisms such as hydrolytic condensation or reductase domains. 47 
 48 
 49 
 50 
 51 
 52 
Figure 1. The surugamide (sur) biosynthetic gene cluster (BGC). Schematic representation of the 53 
sur BGC and domain organization of SurAD, which make cyclic surugamides (1-6) and SurBC, 54 
which makes surugamide F (7). A, adenylation domain; C, condensation domain; E, epimerase 55 
domain; AMPA, 3-amino-2-methylpropionic acid. Grey ovals indicate peptidylcarrier proteins. 56 
 57 
 58 
 59 
Scheme 1. Structures of surugamides. 60 
 61 
The absence of an obvious cis-acting mechanism for off-loading the final peptide from the 62 
terminal PCP domains of SurC and SurD led us to hypothesize that one or more trans-acting release 63 
factors may be encoded by genes within the sur BGC. Inspection of other genes within the BGC 64 
revealed two candidates, which we named surF and surE, that may perform this role. The surF gene 65 
product belongs to InterPro Family IPR029058, which includes enzymes with the characteristic 66 
alpha/beta hydrolase fold harbored by thioesterases.9 Standalone proofreading thioesterases (so-67 
called type II thioesterases) are relatively common within NRPS biosynthetic systems, where they 68 
remove aberrant thioester intermediates from the assembly line.10 However, SurF is bioinformatically 69 
inconsistent with this functionality. For instance, SurF belongs to IPR029058, while type II 70 
thioesterases belong to IPR1223; it also possesses a hydrolase signature motif (GxSxG) of GTSLG, 71 
which differs to that of GHSMG for established type II thioesterases.11 Therefore, we investigated 72 
the possibility that surF encoded a trans-acting release factor. If this were the case, then its deletion 73 
would preclude detection of mature surugamides. To test this hypothesis, we deleted surF in S. albus 74 
S4 and assessed the resulting mutant strain ¨surF) for its ability to produce 1 and 7. LC-HRMS 75 
analysis of chemical extracts prepared from the ¨surF strain revealed that surF is not essential for 76 
the production of 1 or 7 (Figure S6), indicating that SurF is unlikely to be a factor that off-loads the 77 
terminal amino-acyl-S-thioester intermediates from the assembly line, but instead may be a type II 78 
thioesterase with an unusual hydrolase signature motif. 79 
The surE gene encodes a protein belonging to InterPro Family IPR012338, indicating it is a 80 
member of the ȕ-lactamase superfamily, which includes transpeptidases and esterases. Analysis of 81 
SurE indicates that it possesses the Ser-Lys-Tyr-His tetrad active site motif the characteristic of Class 82 
C ȕ-lactamases (Figure S7) and that it is phylogenetically distinct from type I and type II thioesterases 83 
(Figure S8). A recent genetic study of mannopeptimycin biosynthesis suggested that a member of 84 
this protein family, MppK (39% shared amino acid identity with SurE) functioned as a 85 
termination/cyclization protein.12 Therefore, in order to test whether surE encodes a trans-acting off-86 
loading factor, we deleted surE in S. albus S4 and tested the resulting mutant strain for its ability to 87 
produce 1 and 7 by LC-HRMS. This revealed that only trace amounts of 1 and 7 were detectable in 88 
the extract prepared from the ¨surE strain (Figure 2). Complementation of the ¨surE mutant with 89 
pDT2, which contained the surE gene under the control of the constitutive ermE* promoter, restored 90 
production of both 1 and 7 to near wild-type levels and verified that loss of their production was not 91 
due to other mutational events (Figure 2). Taking these findings together, we conclude that SurE is 92 
required for the production of both 1 and 7, presumably because it off-loads the linear aminoacyl-S-93 
thioester intermediate of surugamide A and performs a head-to-tail cyclisation reaction to result in 1 94 
and simply hydrolytically releases the linear aminoacyl-S-thioester intermediate of surugamide F to 95 
result in 7. 96 
 97 
 98 
Figure 2. surE is essential for the production of surugamide A and surugamide F. LC-HRMS 99 
analysis of chemical extracts prepared from the indicated strains. The m/z corresponding to the 100 
[M+H]+ ions derived from 1 (black, C48H81N9O8) and 7 (red, C52H85N11O12) are shown. The intensity 101 
scale for EICs is 1x106 for 1 and is 1x105 for 7. 102 
 103 
We sought to reconstitute these reactions in vitro to corroborate our in vivo data and to 104 
unambiguously determine the function of SurE. SurE was overproduced and purified from E. coli as 105 
an N-terminal hexahistidine tagged variant ((His)6SurE, Figure S9). The cost of the AMPA residue 106 
within 7 led us to first verify the functionality of SurE using a thioester mimic of linear 1 before 107 
embarking on synthesis of the equivalent mimic for 7. Thus, we synthesized an N-acetylcysteamine 108 
(SNAC) thioester mimic of 1 (Figures S10-S13) and assessed the ability of SurE to utilise this 109 
substrate.  When SurE is incubated with SNAC-surugamide A (8) it catalyzes the formation of 1 as 110 
judged by LC-HRMSMS (Figure 3, Figure S14-S16). These data were recently corroborated by a 111 
report in which an ortholog of SurE from S. albidoflavus NBRC12854 catalyzed the same reaction in 112 
vitro with the SNAC thioester mimic of 2, a shunt product of the pathway.13 While our chemical 113 
synthesis of a thioester mimic of 7 was in progress, its synthesis and utilization by SurE was reported 114 
elsewhere.14 Surprisingly, surugamide F was not the major product in vitro and instead SurE produced 115 
a head-to-tail cyclized variant named cyclosurugamide F, which was also retrospectively observed in 116 
low abundance within a crude chemical extract generated from the producing organism. 14 The 117 
authors proposed an intriguing possibility that a cytosolic peptidase may hydrolyze the bond 118 
generated by SurE to result in 7. 14  Taken together, our data and that of others unambiguously 119 
demonstrate that SurE is a trans-acting cyclase that off-loads the terminal linear aminoacyl-S-120 
thioester intermediates of surugamides A and F and performs head-to-tail cyclisation reactions to 121 
result in 1 and 7. 122 
 123 
 124 
Figure 3. LC-HRMS analysis of in vitro SurE reaction with SNAC-surugamide A. (The m/z 125 
corresponding to the [M+H]2+ ions derived from 1 (blue, C48H81N9O8) and 8 (red, C52H90N10O9S) are 126 
shown. The intensity scale for all EICs is 1x106. 127 
 128 
 129 
Although the hypothesis was not rigorously evaluated, MppK was suggested to perform a 130 
function analogous to SurE during the biosynthesis of mannopeptimycin12 and putative orthologs 131 
have been observed within the desotamide and ulleungmycin BGCs.15,16 This led us to evaluate how 132 
widespread the SurE off-loading mechanism may be within NRPS biosynthetic systems. To do this, 133 
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we identified organisms harboring sententious orthologs of SurABCD and SurE using a 134 
multigeneblast database that we previously built with 1,421 filamentous Actinobacterial 135 
genomes.17,18 Next, the candidate genomes that arose from this analysis were subjected to analysis by 136 
antiSMASH 4.1.019 and the corresponding output was used to manually curate a list of NRPS 137 
biosynthetic systems lacking an embedded TE domain, but harboring an adjacent SurE ortholog. 138 
These criteria were satisfied by 174 NRPS systems harbored by 166 organisms in our dataset, 139 
suggesting that overall, ~11% of filamentous Actinobacteria harbor an NRPS biosynthetic system 140 
that utilizes a release strategy involving a trans-acting cyclase belonging to the ȕ-lactamase 141 
superfamily. 142 
Anecdotal observations during the manual curation of antiSMASH analyses suggested that 143 
several of the identified biosynthetic systems were related to one another. In order to explore this 144 
possibility, we used BiG-SCAPE20 to generate a BGC similarity network of the NRPS systems 145 
identified above (Figure 4, Table S1). The final network was grouped into 15 subnetworks and 12 146 
singletons. In addition to 174 nodes for the BGCs identified here, three additional nodes were 147 
generated from entries within the MIBiG database of experimentally characterized BGCs21; these 148 
three nodes correspond to BGCs that direct the biosynthesis of surugamides5, ulleungmycin16 and 149 
dechlorocuracomycin22. Surprisingly, the BGCs for desotamide15 and mannopeptimycin12, which are 150 
also present within the MIBiG database, were not resolved within the network, implying that they are 151 
distantly related systems. The number of modules encoded within a biosynthetic system, which 152 
ranged from 4-10 modules and is color-coded within Figure 4, was a major factor that influenced 153 
subnetwork formation (Figure 4, Table S1). SurE itself is capable of accepting amino-S-acyl 154 
thioester substrates 8 and 10 amino acid residues in length, however our bioinformatics analyses 155 
suggests that SurE and/or its orthologs may be able to utilise substrates composed of just four amino 156 
acid residues. Future studies will interrogate the molecular rules underpinning substrate recognition 157 
by SurE. 158 
 159 
 160 
 161 
Figure 4. Gene cluster similarity network for NRPS BGCs without an embedded thioesterase 162 
but encoding a SurE ortholog. Each node represents a BGC and is color-coded based on the number 163 
of its putative biosynthetic modules. The node table is shown in Table S1. 164 
 165 
In summary, we have identified and characterized in vivo and in vitro a trans-acting release 166 
factor, SurE, that off-loads surugamides via macrolactamization from their respective assembly lines. 167 
Based on our bioinformatic analyses, we propose that this release mechanism is relatively widespread 168 
among Actinobacteria. This work expands the paradigmatic understanding of how non-ribosomal 169 
peptides are off-loaded from terminal PCP domains in NRPS assembly lines and in the process has 170 
identified a standalone (thereby more amenable to augmentation) release factor that could aid 171 
reengineering of non-ribosomal peptide biosynthesis. As access to genomic data increases and 172 
bioinformatics approaches become more robust and sophisticated, we should expect and indeed look 173 
forward to discovering the myriad of ways nature has evolved biosynthetic processes. 174 
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Growth media, strains, cosmids, plasmids and other reagents. Escherichia coli strains 
were cultivated using Lennox agar (LA) or broth (LB) and Streptomyces strains were propagated on 
mannitol-soya flour agar or ISP2 broth.1 Culture media was supplemented with antibiotics as required 
DWWKH IROORZLQJFRQFHQWUDWLRQVDSUDP\FLQȝJPOFDUEHQLFLOOLQȝJPOK\JURP\FLQ
ȝJPO NDQDP\FLQ  ȝJPO QDOLGL[LF DFLG  ȝJPO (Q]\PHV ZHUH SXUFKDVHG IURP 1HZ
England Biolabs unless otherwise stated. Oligonucleotides were purchased from Integrated DNA 
Technologies and are described in Table S2. The DNA constructs and bacterial strains used in this 
study are listed in Table S3. 
Construction and complementation of mutant strains. The surE and surF genes were 
deleted using the ReDirect PCR targeting system2 with Cos994. Cos994 was identified by screening 
a previously constructed S. albus S4 cosmid library3 by PCR using primers DT159 and DT160, which 
targeted an internal fragment of surF. Cos994 was insert-end sequenced using primers RFS184 and 
RFS185 and the resulting reads were mapped to the S. albus S4 genome4,5 in order to establish the 
sequence of the cloned insert. Gene disruption cassettes consisting of an oriT and the apramycin 
resistance gene, aac(3)IV from pIJ7732 were generated by PCR using primers DT161 and DT162 
(surE), and DT167 and DT168 (surF) containing 40 nt of homology that included the start and stop 
codons of each gene and 37 nt upstream or downstream. The resulting gel purified PCR products 
were used to delete surE or surF from Cos994 by recombineering with E. coli GB05-red6. 
Mutagenised cosmids were electroporated into E. coli ET12567/pUZ8002 and subsequently 
mobilized to S. albus S4 by conjugation as described.1 Transconjugants were selected for apramycin 
resistance and kanamycin sensitivity. The integrity of mutant strains was verified by PCR. The 
FRPSOHPHQWHG¨surE strain was generated as follows. The surE gene PCR amplified from S. albus 
S4 genomic and cloned into pIJ102577 at the NdeI and HindIII sites. The resulting plasmid (pDT2) 
was sequenced using RFS582 and DT186 to verify the integrity of cloned insert and mobilised by 
conjugal transfer into the S. albus 6ǻsurE. The resulting strain was verified by PCR. 
Generation of chemical extracts and LC-HRMS analysis. S. albus strains were first 
cultured in 10 ml of LB while shaking (220 rpm) at 30 °C for 3 days, at which point the entire culture 
was added to ISP2 broth (50 ml in a 250 ml flask) and incubated at 30 °C with shaking (180 rpm) for 
4 days. Bacterial cells were removed by centrifugation, and metabolites were extracted from the 
supernatant twice with two volumes of ethyl acetate. Extracts were pooled and concentrated in vacuo. 
The remaining residue was resuspended in 0.7 ml of 100% MeOH. Two microliters of methanolic 
extract were injected into a Bruker MaXis Impact II mass spectrometer coupled with a Dionex 3000 
RS UHPLC equipped with an Agilent C18 column (2.1 × 100 mm). The solvent system was as 
follows: solvent A, 0.1% formic acid in water; solvent B, 0.1% formic acid in acetonitrile. The 
following gradient was used: 0-5 min, 5% B; 5-20 min, 5-100% B; 20-25 min, 100% B; 25-27 min, 
100-5% B. The flow rate was 0.2 ml/min. Calibration was achieved with 1 mM sodium formate at 
the beginning of each run. 
Overproduction and Purification of Recombinant Protein. The surE PCR amplified from 
extracted S. albus S4 genomic DNA using primers DT206 and DT213 (Table S2). The resulting PCR 
product was gel purified and digested with NdeI and XhoI endonucleases, and ligated with T4 DNA 
ligase to pET28a cut with the same enzymes to result in pET28-surE. The integrity of the cloned 
insert was verified by DNA sequencing and subsequently used to transform E. coli BL21-Gold(DE3) 
(Agilent Technologies). For overproduction of the recombinant protein, a starter culture E. coli cells 
harboring pET28-surE were cultured overnight in 10 ml LB supplemented with kanamycin while 
shaking (180 rpm) at 37 °C. Five milliliters of the starter culture were used to inoculate 500 ml of 
Super Broth auto-induction media (Formedium) and cultured for 48 hours while shaking (180 rpm) 
at 16°C. Bacterial cells were collected by centrifugation, resuspended in lysis buffer (50 mM HEPES, 
500 mM NaCl, 10 mM imidazole, 1 mM EDTA, protease inhibitor, DNAse I, pH 7.5) and lysed using 
an ultrasonic probe (40% power, 2 x× 90 seconds, 1 pulse s-1). Lysates were clarified by centrifugation 
and passed through a 20 ml BioRad Econo Pac column loaded with 3 ml Ni-NTA resin (Generon) by 
gravity flow. The resin was washed with two column volumes of wash buffer (50 mM HEPES, 200 
mM NaCl, 50 mM imidazole, 1 mM EDTA, pH 7.5). Protein was eluted from the resin with elution 
buffer (50 mM HEPES, 200 mM NaCl, 300 mM imidazole, 1 mM EDTA, pH 7.5) and analysed by 
SDS-PAGE. Elution fractions containing the protein of interest were pooled and concentrated using 
an Amicon spin filter (Merck) and subjected to buffer exchange by dialysis into storage buffer (50 
mM HEPES, 200 mM NaCl, pH 7.5). 
Chemical Synthesis of SNAC-surugamide A. Linear surugamide A was synthesised as a 
protected peptide as follows. 2-Chlorotrityl resin (100 mg, 1.00-1.80 mmol g-1) was swollen in DMF 
(10 ml) for 30 minutes. The resin was transferred to the peptide synthesiser and coupled twice with 
Fmoc D- Leu (1 mmol) using DIC (1 mmol) and Oxyma (1 mmol) for 30 minutes with microwave 
irradiation. The resin was washed with DMF (2 × 10ml) after the coupling step. Fmoc deprotection 
was conducted using 20% pipiridine in DMF (2 × 10ml) and washed with DMF (2 × 10ml). The 
coupling and deprotection cycle was repeated using Fmoc D-Phe, Fmoc L-Ile, Fmoc L-Lys(Boc), 
Fmoc D-Ile, Fmoc L-Ile, Fmoc D-Ala and Boc L-Ile. The resin was filtered and washed successively 
with DMF (2 × 10ml) and DCM (2 × 10ml). The 2-chlorotrityl resin was deprotected using 
hexafluoroisopropanol in DCM (1:4, 3ml) for 2 hours after which time the resin was filtered and 
washed with DCM (3 × 10ml). The solvents were removed in vacuo resulting in an off-white solid 
which was used without further purification.  
In vitro SNAC assay. The ability of (His)6SurE to utilise SNAC-surugamide A was assessed 
in vitro using the following reaction conditions in a final volume of 100 ȝl: 50 mM HEPES (pH 7.5), 
0.1 mM SNAC-surugamide A, 20 ȝJRI+LV6SurE. The enzymatic reaction or SNAC-surugamide A 
alone were incubated at 30 °C. After 5 hrs of incubation, samples were treated with ȝ/RI
TFA and extracted with Phenomenex Strata-;/&ȝPPJPl) solid-phase extraction 
column and a vacuum manifold. Metabolites were eluted from the column with ȝl of 100 % 
methanol. The methanolic extract was either diluted 1:1 with 100% methanol or mixed 1:1 with crude 
natural product prior to centrifugation for 10 mins at 16,000g to remove any insoluble material before 
analysis by LC-HR-ESI MSMS on a Bruker MaXis Impact II TOF mass spectrometer equipped with 
a Dionex UltiMate 3000 high-performance liquid chromatography apparatus with conditions 
described previously8. 
The crude protected peptide was dissolved in DCM (2 ml) to which was added DIC (63 mg, 
0.5 mmol), HOBT (67 mg, 0.5 mmol) and N-acetylcysteamine (60 mg, 0.5 mmol). The solution was 
stirred at room temperature overnight followed by removal of solvent in vacuo. The crude thioester 
was globally deprotected by dissolving in 9:1 TFA:DCM and stirred at 0 ºC to room temperature  for 
3 hours.  The volatiles were removed in vacuo and the crude sample dissolved in cold water (10 ml). 
ice cold diethyl ether was used to precipitate the peptide which was collected by centrifugation (4 ºC). 
The crude SNAC peptide was purified by preparative HPLC using Agilent 1260 Mass Directed 
Preparative +3/&LQVWUXPHQWHTXLSSHGZLWKD3KHQRPHQH[.LQHWH[(92&FROXPQȝPî
21.2 mm). The solvent system was as follows: solvent A, 0.1% formic acid in water; solvent B, 0.1% 
formic acid in acetonitrile. The following gradient was used: 0-2 min, 5% B; 2-12 min, 5-95% B; 12-
14 min, 95% B; 14-15 min, 100-5% B. The flow rate was 20 ml/min.) and solvent removed in vacuo 
resulting in the pure peptide as a white solid (8 mg). The final peptide was subjected to NMR 
spectroscopy on a JEOL ECA600 series II 600MHz NMR spectrometer 1H NMR (600 MHz, D2O) 
7.29 ± 7.26 (m, 2H), 7.23 ± 7.19 (m, 3H), 4.68 (m, 1H), 4.41 (dd, J = 10.1, 3.9 Hz, 1H), 4.35 (q, J = 
7.2 Hz, 1H), 4.25 (dd, J =  9.4, 5.3 Hz, 1H), 4.21 (d, J = 7.1 Hz, 1H), 4.02 (d, J = 8.0 Hz, 1H), 3.93 
(d, J = 7.9 Hz, 1H), 3.70 (s, 1H), 3.24 (t, J = 6.3 Hz, 2H), 3.20 (dd, J = 14.1, 5.5 Hz, 1H), 2.96 ± 2.82 
(m, 6H), 1.86 (s, 3H), 1.80 (ddd, J = 9.9, 7.4, 4.5 Hz, 2H), 1.71 (tt, J = 11.4, 5.6 Hz, 1H), 1.67 ± 1.52 
(m, 8H), 1.45 ± 1.32 (m, 4H), 1.31 (d, J = 7.2 Hz, 3H), 1.29 ± 1.24 (m, 1H, 1.20 (ddd, J = 13.6, 7.5, 
3.5 Hz, 1H), 1.17 ± 1.02 (m, 4H), 0.94 (dt, J = 13.7, 7.8 Hz, 1H), 0.89 (d, J = 6 9 Hz, 3H), 0.85 ± 0.80 
(m, 14H), 0.77 (ddd, J = 7.8, 6.5, 1.3 Hz, 10H), 0.66 (t, J = 7.4 Hz, 3H), 0.49 (d, J = 6.9 Hz, 3H).0.5 
(d, J = 6.9 Hz, 3H); HMRSC52H91N10O9S+ [M+H]+  requires 1031.6686; found 1031.6712 ǻ
2.5ppm). 
Bioinformatics analysis. A bespoke multigeneblast9 database of 1,421 Prokka-annotated10 
Actinobacterial genomes (Genera: Actinobactera, Actinomadura, Actinospica, Amycolatopsis, 
Kitasatospora, Micromonospora, Nocardia, Saccharopolyspora, Planomonospora, Pseudonocardia, 
Salinispora, Streptacidiphilus and Streptomyces) was previously constructed11. SurABCDE were 
used as a multigeneblast query with the default settings. The resulting output was inspected manually 
to identify genomes harboring putative NRPS systems with an adjacent SurE ortholog. The resulting 
complete genomes and draft genome contigs harboring such systems were subjected to antiSMASH 
analysis (webserver version 4.1.0).12 The resulting output was manually inspected to determine if the 
putative terminal biosynthetic module harbored an embedded TE domain. Systems harbored near the 
end of a contig were discarded in order to remove truncated genes from future analyses. In total, 174 
NRPS BGCs were identified that appeared to lack an embedded thioesterase domain and harbor an 
adjacent SurE ortholog. The corresponding antiSMASH-generated GenBank files for these systems 
were redacted to remove all genes except those encoding the putative chemical scaffold and off-
loading factor (i.e. putative NRPS genes and the SurE ortholog) in order to make generation the BGC 
similarity network more coherent. BiG-SCAPE13 was used with the redacted GenBank files to 
generate a BGC similarity network. The graphic displayed in Figure 4 was generated using Cytoscape 
3.7.114 and the raw BiG-SCAPE is available from via Figshare 
(https://doi.org/10.6084/m9.figshare.7665494.v1). The multi-sequence alignment depicted in Figure 
S7 was generated using the Geneious R8.1.7 implementation of MUSCLE. 15 The phylogeny of SurE, 
ȕ-lactamses and thioesterases was constructed from a MUSCLE multi-sequence alignment using the 
Geneious R8.1.7 implementation of PhyML 3.2.2.16 The thioesterase sequences used to construct the 
phylogeny were obtained from accession provided by.17 
 
 Figure S1. Streptomyces albus S4 produces surugamide A (1) and surugamide F (7). (A) LC-HRMS 
analysis of chemical extracts prepared from S. albus S4. The base peak chromatogram (BPC) and the 
m/z corresponding to the [M+H]+ ions derived from surugamide A (red, C48H81N9O8) and surugamide 
F (green, C52H85N11O12) are shown. 
 
 
 Figure S2. The measured (red) and simulated (orange) [M+H]+ mass spectra for surugamide A. 
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Figure S3. The measured (green) and simulated (orange) [M+H]+ mass spectra for surugamide F. 
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 Figure S4. MS2 fragmentation of surugamide A. Mapped fragments are color-coded. Green text 
indicates an unobserved ion. 
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Figure S5. MS2 fragmentation of surugamide F. Mapped fragments are color-coded. 
 
 Figure S6. SurF is not essential for the production of 1 or 7. LC-HRMS analysis of chemical extracts 
prepared from the indicated strains. The m/z corresponding to the [M+H]+ ion derived from 1 
(C48H81N9O8) and 7 (C52H85N11O12) are shown. The intensity scale is 1x106 for EICs of 1 and 1x105 
for EICs of 7. 
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 Figure S7. MUSCLE alignment of SurE with closely related proteins. MppK (discussed in the text) 
is a proposed cyclase involved of mannopeptimycin. 4Y7P, 1IKI, 1CEF are PDB accessions for 
structurally characterised D-peptidases. The active site tetrad Ser-Lys-Tyr-His is indicated by red 
asterisks. 
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 Figure S8. Maximum likelihood phylogeny of SurE and related proteins. The mid-root phylogeny is 
based on SurEW\SH,DQG7\SH,,WKLRHVWHUDVHVDQGȕ-lactamases. SH-like support values are indicated 
at nodes as decimal values. The amino acid sequences used here, with the exception of SurE, MppK 
and the ȕ-lactamase PDB entries (shaded blue), were obtained from. 17. Pink text indicates cis-
encoded type II thioesterases. TE_I, type I thioesterase; TE_II, type II thioesterase; P = from PKS 
system; N = from NRPS system; PN = from PKS-NRPS system; uk = unknown. The scale bar 
represents 10% sequence divergence. 
  
  
 
 
 
Figure S9. SDS-PAGE analysis of purified (His)6SurE from E. coli BL21-Gold(DE3). M, marker; F, 
Ni-NTA column flow through; W1, first wash; W2, second wash; E1-E3, elutions 1-3. Buffers for 
washing and elution indicated in the methods section. 
  
 Figure S10. LC-HRMS analysis of SNAC-surugamide A (8). The base peak chromatogram (BPC) 
and the m/z corresponding to the [M+H]+ ion derived from 8 (C52H90N10O9S) is shown in blue.  
  
8
 Figure S11. The measured (blue) and simulated (orange) [M+H]+ mass spectra for SNAC-
surugamide A.   
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Figure S12. MS2 fragmentation of SNAC-surugamide A (8). Mapped fragments are color-coded. 
Green text indicates an unobserved ion. 
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 Figure S13. 1H NMR of SNAC-surugamide A. 
 
 
 
  
 
Figure S14. The measured (red) and simulated (orange) [M+H]+ mass spectra for surugamide A 
produced by SurE in vitro. 
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Figure S15. MS2 fragmentation of surugamide A produced by SurE in vitro. Green text indicates an 
unobserved ion. 
  
  
Figure S16. LC-HRMS analysis of in vitro reactions with 8. The BPC and EICs for 8 (red, 
C52H90N10O9S, [M+H]2+) and 1 (blue, C48H81N9O8, [M+H]2+) for each sample. Samples include (from 
top down): 8 alone, 8 + SurE, crude extract from S. albus WT, co-injection of 8 + SurE with crude 
extract from S. albus WT. 
  
Table S1. NRPS biosynthetic systems lacking an embedded thioesterase domain and with an adjacent SurE ortholog 
Accession Taxonomy Number of Modules 
BiG-SCAPE 
gene cluster 
family 
BGCs in the network    
JOCL01000027.1 Streptomyces rimosus subsp. rimosus strain NRRL WC-3877 6 1899 
LGCU01000069.1 Streptomyces rimosus subsp. rimosus strain NRRL WC-3898 6 1899 
JNWV01000002.1 Streptomyces flaveolus strain NRRL B-1589 10 1915 
KQ948566.1 Streptomyces longwoodensis strain DSM 41677 10 1838 
FKJH01000063.1 Streptomyces sp. F-7 10 1838 
LN831790.1 Streptomyces leeuwenhoekii 10 1838 
JNWX01000027.1 Streptomyces rimosus subsp. rimosus strain NRRL B-16073 6 1899 
JOBS01000025.1 Streptomyces rimosus subsp. rimosus strain NRRL WC-3558 6 1899 
LMWF01000128.1 Streptomyces rimosus subsp. rimosus strain NRRL WC-3897 6 1899 
JMGX01000001.1 Streptomyces rimosus strain R6-500MV9 6 1899 
JOCN01000027.1 Streptomyces lavendulae subsp. lavendulae strain NRRL WC-3532 6 1899 
JOJH01000022.1 Streptomyces sp. NRRL WC-3725 10 1915 
LWAB01000002.1 Streptomyces sp. H-KF8 10 1838 
JODT01000010.1 Streptomyces achromogenes subsp. achromogenes strain NRRL B-2120 10 1915 
JOJG01000030.1 Streptomyces sp. NRRL WC-3683 10 1915 
JOEX01000030.1 Streptomyces lavendulae subsp. lavendulae strain NRRL B-2775 6 1899 
LGCR01000071.1 Streptomyces rimosus subsp. rimosus strain NRRL WC-3875 6 1899 
CM002273.1.1 Streptomyces sp. PVA 94-07 6 1904 
JOGU01000009.1 Streptomyces griseus subsp. griseus strain NRRL F-5621 6 1904 
BBNN01000019.1 Streptomyces sp. NBRC 110035 10 1838 
CP013219.1 Streptomyces hygroscopicus subsp. limoneus 10 1915 
CP016174.1 Amycolatopsis orientalis B-37 9 1851 
FOPQ01000016.1 Amycolatopsis regifaucium strain DSM 45072 9 1851 
LJJF01000001.1.2* Streptomyces sp. MJM8645 10 1915 
CP006259.1 Streptomyces collinus Tu 365 10 1838 
JOIC01000025.1 Streptomyces sp. NRRL F-3307 10 1915 
KQ948863.1 Streptomyces bungoensis strain DSM 41781 10 1838 
LGUX01000036.1 Streptomyces antibioticus strain NRRL B-2032 10 1915 
LMTQ02000010.1 Streptomyces sp. AVP053U2 10 1838 
BBOU01000038.16 Streptomyces hygroscopicus subsp. hygroscopicus 10 5 
BCAN01000035.1 Streptomyces hygroscopicus subsp. hygroscopicus 10 5 
JOBN01000024.1 Streptomyces rimosus subsp. rimosus strain NRRL WC-3925 6 1899 
LBDA02000012.1 Streptomyces malaysiense strain MUSC 136 10 1915 
LGDZ01000181.1 Streptomyces sp. NRRL B-3648 10 1915 
FNTM01000001.1 Streptomyces sp. 2133.1 10 1849 
BBUZ01000026.1 Streptomyces sp. NBRC 110028 10 5 
LAKD02000032.1 Streptomyces antioxidans strain MUSC 164 10 5 
JOCM01000023.1 Streptomyces rimosus subsp. rimosus strain NRRL WC-3876 6 1899 
JOET01000024.1 Streptomyces rimosus subsp. rimosus strain NRRL B-2661 6 1899 
JNYK01000022.1 Streptomyces rimosus subsp. rimosus strain NRRL B-8076 6 1899 
JOCK01000027.1 Streptomyces peucetius strain NRRL WC-3868 6 1899 
KQ948353.1 Streptomyces corchorusii strain DSM 40340 10 1915 
LIPD01000005.1 Streptomyces sp. CB02056 9 1915 
JOCJ01000019.1 Streptomyces sp. NRRL WC-3744 10 1915 
JOCB01000020.1 Streptomyces sp. NRRL S-31 10 1915 
JOJJ01000019.1 Streptomyces rimosus subsp. rimosus strain NRRL WC-3929 6 1916 
CM002271.1.2* Streptomyces sp. GBA 94-10 18 1821 
CP004370.1.2* Streptomyces albus J1074 18 1821 
LGCV01000363.1 Streptomyces rimosus subsp. pseudoverticillatus strain NRRL WC-3896 6 1899 
JOBO01000008.1 Streptomyces rimosus subsp. rimosus strain NRRL WC-3927 6 1916 
CM002271.1.1 Streptomyces sp. GBA 94-10 6 1904 
LGCP01000253.1 Streptomyces sp. NRRL WC-3701 6 1899 
JOIV01000032.1 Streptomyces sp. NRRL S-1896 10 1915 
JOCP01000022.1 Streptomyces rimosus subsp. rimosus strain NRRL WC-3880 6 1899 
LGUY01000146.1 Kitasatospora aureofaciens strain NRRL B-2658 6 1899 
CP004370.1.1 Streptomyces albus J1074 6 1820 
CP009802.1.1 Streptomyces sp. FR-008 6 1820 
FMZK01000015.1 Streptomyces emeiensis strain CGMCC 4.3504 10 1838 
LFVR01000013.1 Streptomyces regensis strain NRRL B-11479 10 1915 
JOCO01000023.1 Streptomyces rimosus subsp. rimosus strain NRRL WC-3882 6 1899 
JOCR01000021.1 Streptomyces rimosus subsp. rimosus strain NRRL WC-3900 6 1899 
JOIU01000014.1 Streptomyces sp. NRRL S-1022 10 1915 
JNWP01000024.1 Streptomyces capuensis strain NRRL B-12337 6 1899 
JOBW01000024.1 Streptomyces rimosus subsp. rimosus strain NRRL WC-3924 6 1916 
CP015588.1 Streptomyces alfalfae ACCC40021 10 1915 
JOCH01000022.1 Streptomyces sp. NRRL WC-3703 6 1899 
KV757140.1 Streptomyces sporocinereus strain OsiSh-2 10 5 
LXIC01000010.1 Streptomyces sp. RTd22 10 5 
JOCU01000001.1 Streptomyces flaveus strain NRRL WC-3505 10 1915 
LN997842.1 Streptomyces reticuli 10 1915 
JNYR01000027.1 Streptomyces rimosus subsp. rimosus strain NRRL ISP-5260 6 1899 
CP003720.1 Streptomyces hygroscopicus subsp. jinggangensis TL01 10 1915 
JOHT01000002.1 Streptomyces sp. NRRL F-5053 6 1906 
JODF01000025.1 Streptomyces sp. NRRL S-920 10 1915 
FOWC01000006.1 Amycolatopsis rubida strain DSM 44637 9 1918 
KB913032.1 Amycolatopsis alba DSM 44262 9 1918 
JOBP01000016.1 Streptomyces rimosus subsp. rimosus strain NRRL WC-3930 6 1916 
JOFU01000020.1 Streptomyces griseofuscus strain NRRL B-5429 10 1915 
LGUU01000283.1 Streptomyces decoyicus strain NRRL 2666 10 1849 
FNSG01000001.1 Streptomyces sp. 2112.2 10 1849 
JOIX01000003.1 Streptomyces sp. NRRL S-337 10 1915 
LGDX01000188.1 Streptomyces sp. NRRL WC-3723 10 1915 
CP019457.1 Streptomyces lydicus GS93 5 1830 
JNZA01000037.1 Streptomyces lydicus strain NRRL ISP-5461 5 1830 
JOCC01000027.1 Streptomyces sp. NRRL WC-3702 6 1899 
JNWN01000025.1 Streptomyces sp. NRRL B-11253 6 1899 
LGCO01000080.1 Streptomyces rimosus subsp. rimosus strain NRRL WC-3909 6 1899 
FNSO01000004.1 Amycolatopsis tolypomycina strain DSM 44544 10 1919 
JPRA01000062.1 Amycolatopsis mediterranei strain HP-130 10 1919 
CP009802.1.2* Streptomyces sp. FR-008 18 1821 
KB898235.1 Streptomyces sp. CNY228 18 1821 
FNKS01000001.1 Streptomyces sp. KS_16 10 1849 
LLZJ01000403.1 Streptomyces violaceusniger strain NRRL F-8817 10 5 
FNST01000002.1 Streptomyces melanosporofaciens strain DSM 40318 10 5 
BDFA01000034.1 Streptomyces sp. SPMA113 10 5 
CP015726.1 Streptomyces sp. RTd22 10 5 
CP009438.1 Streptomyces glaucescens 10 1838 
JOJM01000018.1 Streptomyces sp. NRRL B-1347 9 1917 
FMBX01000012.1 Streptomyces sp. ScaeMP-6W 18 1821 
MNPQ01000023.1 Streptomyces albidoflavus strain OsiLf-2 18 1821 
JOEO01000025.1 Streptomyces rimosus subsp. rimosus strain NRRL B-2626 6 1899 
FNTP01000001.1 Streptomyces sp. 2112.3 10 1849 
MIBiG_BGC0001792.1 Surugamide A/D (from Streptomyces albus) 18 1821 
CP016824.1.1 Streptomyces sampsonii KJ40 18 1821 
LGCT01000071.1 Streptomyces rimosus subsp. rimosus strain NRRL WC-3899 6 1899 
JOFM01000024.1 Streptomyces capuensis strain NRRL B-3501 6 1899 
JOCQ01000017.1 Streptomyces rimosus subsp. rimosus strain NRRL WC-3904 6 1916 
JNWZ01000005.1 Kitasatospora phosalacinea strain NRRL B-16230 4 1893 
JODW01000005.1 Streptomyces globisporus subsp. globisporus strain NRRL B-2293 4 1893 
FNUJ01000015.1 Amycolatopsis pretoriensis strain DSM 44654 9 1918 
MQUQ01000027.1 Amycolatopsis coloradensis strain DSM 44225 9 1918 
CP019458.1 Streptomyces autolyticus CGMCC0516 10 5 
JJNO01000003.1 Streptomyces rimosus R6-500 6 1899 
JNYY01000016.1 Amycolatopsis vancoresmycina strain NRRL B-24208 10 1919 
KB913037.1 Amycolatopsis balhimycina FH 1894 strain DSM 44591 10 1919 
JOBD01000008.1 Streptomyces lavenduligriseus strain NRRL ISP-5487 10 1915 
JOIK01000003.1 Streptomyces hygroscopicus subsp. hygroscopicus strain NRRL B-1477 10 5 
LGCS01000311.1 Streptomyces rimosus subsp. rimosus strain NRRL WC-3873 6 1899 
CP018627.1 Streptomyces hygroscopicus XM201 10 5 
LLZK01000014.1 Streptomyces sp. NRRL S-1521 10 1915 
JOGD01000011.1 Streptomyces sp. NRRL S-1868 6 1906 
KB891896.1 Streptomyces sp. MspMP-M5 5 1830 
BBUZ01000046.1 Streptomyces sp. NBRC 110028 6 1936 
CP020567.1 Kitasatospora aureofaciens strain DM-1 6 1936 
CP006567.1 Streptomyces rapamycinicus NRRL 5491 10 5 
LOBU02000031.1 Amycolatopsis regifaucium strain GY080 9 1851 
JTCK01000091.1 Streptomyces sp. CNQ431 6 1904 
CM002273.1.2* Streptomyces sp. PVA 94-07 18 1821 
JOER01000020.1 Kitasatospora aureofaciens strain NRRL B-2657 6 1936 
JOFK01000006.1 Streptomyces avellaneus strain NRRL B-3447 6 1936 
LAYX01000005.1 Streptomyces sp. KE1 5 1904 
CP003777.1 Amycolatopsis mediterranei RB 10 1919 
CP016824.1.2* Streptomyces sampsonii KJ40 5 1855 
JOII01000014.1 Streptomyces albidoflavus strain NRRL B-1271 5 1855 
JOGG01000034.1 Streptomyces sp. NRRL B-5680 6 1936 
FNSJ01000001.1 Streptomyces sp. 2314.4 10 1849 
FNSB01000002.1 Streptomyces sp. 2224.1 10 1849 
KN549147.1 Streptomyces sp. M10 6 1904 
JABQ01000025.1 Streptomyces sp. PRh5 10 5 
JPLW01000002.1 Amycolatopsis sp. MJM2582 9 1918 
CP003410.1 Amycolatopsis orientalis HCCB10007 9 1918 
CP019779.1 Streptomyces sp. MOE7 4 1830 
JOGN01000041.1 Streptomyces griseus subsp. griseus strain NRRL F-5618 5 1855 
MIBiG_BGC0001569.1 Dechlorocuracomycin (from Streptomyces noursei) 6 1810 
CP011533.1 Streptomyces noursei ATCC 11455 6 1810 
FNTA01000002.1 Amycolatopsis lurida strain DSM 43134 9 1918 
JPRF03000087.1 Kitasatospora aureofaciens strain ATCC 10762 6 1936 
LBHA01000110.1 Kitasatospora aureofaciens strain NRRL 2209 6 1936 
CP017157.1 Streptomyces lydicus 103 5 1830 
MVFC01000034.1 Streptomyces tsukubensis strain F601 6 1904 
JMQJ01000071.1 Amycolatopsis mediterranei strain DSM 40773 10 1919 
JOIQ01000012.1 Streptomyces sp. NRRL F-3213 9 1918 
LK022848.1 Streptomyces iranensis 10 5 
JODE01000022.1 Streptomyces sp. NRRL S-515 6 1889 
JODJ01000024.1 Streptomyces sp. NRRL S-575 6 1889 
CP014485.1.2* Streptomyces albus SM254 18 1821 
JMQG01000012.1 Amycolatopsis mediterranei strain DSM 46096 10 1919 
LQCI01000007.1 Amycolatopsis regifaucium strain GY080 9 1851 
LWSF01000010.1 Amycolatopsis sp. M39 9 1918 
JHDU01000021.1 Streptomyces wadayamensis strain A23 5 1855 
CP003987.1 Streptomyces sp. 769 6 1810 
CP014485.1.1 Streptomyces albus SM254 6 1820 
FNSM01000001.1 Streptomyces sp. TLI_105 4 1893 
MIBiG_BGC0001814.1 Ulleungmycin (from Streptomyces sp. KCB13F003) 6 1810 
FPJG01000006.1 Amycolatopsis australiensis strain DSM 44671 9 1918 
Singletons    
ASHX02000001.1 Streptomyces thermolilacinus SPC6 4 0 
CP017316.1 Streptomyces rubrolavendulae MJM4426 6 1828 
CP019798.1 Streptomyces sp. fd1-xmd 5 1833 
CP020563.1 Kitasatospora albolonga YIM 101047 6 1834 
FNON01000001.1 Amycolatopsis xylanica strain CPCC 202699 6 1840 
JNXP01000027.1 Streptomyces seoulensis strain NRRL B-24310 4 1865 
JOHO01000003.1 Streptomyces sp. NRRL S-350 6 1905 
KB890716.1 Streptomyces sp. LaPpAH-202 6 1922 
KB897508.1 Salinispora pacifica CNY331 5 1924 
LGDY01000106.1 Nocardia sp. NRRL S-836 7 1946 
LJJF01000001.1 Streptomyces sp. MJM8645 6 1952 
NBCN01000013.1 Streptomyces sp. CB03238 5 1969 
aAccession numbers provided are for whole genomes or draft genome contigs harboring the BGC 
*Denotes accession numbers which have been appended with ³´ in cases where a whole genome harbors more than one SurE-
containing BGC.    
 
 
 
 
 
 
 
 
  Table S2. Oligonucleotide primers used in this study 
Primer name 6HTXHQFH¶- ¶ Description 
DT045 tgaccgggaacaccgtgctcac Hygromycin resistance cassette 
DT046 cggaaggcgttgagatgcagtt Hygromycin resistance cassette 
DT159 aacgtgtttcacctgggctc Identification of Cos994 
DT160 acggccgaaaagaagggcaa Identification of Cos994 
DT161 agggtccggtgggttgcagtgggcgcaggggacgcagtgattccggggatccgtcgacc ReDirect primers for deleting surE 
DT162 gcgtcgcggggcgcccggccggccgagtggggcgggtcatgtaggctggagctgcttc ReDirect primers for deleting surE 
DT163a agctggtcatgcagttcgtct Verification of ¨VXU( 
DT164a atcgtgggtcaccatcagctc Verification of ¨VXU( 
DT167 cggatcacgcgggacggccgaaaagaagggcaagttgtgattccggggatccgtcgacc ReDirect primer for deleting surF 
DT168 acgccgcgcgaggcgtctgccggcccccctgccggttcatgtaggctggagctgcttc ReDirect primer for deleting surF 
DT171 acttcctcaaccacaccacg Verification of ¨surF 
DT172 cggttcaacgtgtttcacct Verification of ǻsurF 
DT186 tggacagttgcctgctgcgt Sequencing surE in pDT2 
DT206 atctcatatggtgggtgccgagggggcgga Construction of pET28-surE 
DT210 atcacatatggtgggtgccgagggggcgga Construction of pDT2 
DT211 atctaagctttcagagccggtgcatggccc Construction of pDT2   
DT213 atcactcgagtcagagccggtgcatggccc Construction of pET28-surE 
RFS115 cattcttcgcatcccgcct Apramycin resistance cassette 
RFS116 ctccttccgtagcgtcc Apramycin resistance cassette 
RFS184 ccattattatcatgacattaa Cos994 insert-end sequencing  
RFS185 gtccgtggaatgaacaatgg Cos994 insert-end sequencing  
RFS582 agcccgacccgagcacg Sequencing surE in pDT2 
*Non-homologous sequences are bolded and restriction endonuclease sites are underlined 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table S3. Bacterial strains, cosmids and plasmids used in this study 
Strain/cosmid/plasmid Description Reference 
Streptomyces   
S. albus S4 Streptomyces albus S4 wildtype 18 
ǻsurE S4 surE mutant, AprR This study 
¨surE attB 
ĭBT1::pDT2 
S4 surE mutant complemented with surE expressed from 
the ermE* promoter; AprR, HygR This study 
ǻsurF S4 surF mutant, AprR This study 
Escherichia coli   
BL21-Gold(DE3) Protein production host Agilent Technologies 
GB0R-red RecET recombineering host 6
 
ET12567 Non-methylating host to for conjugal transfer of DNA into Streptomyces (dam, dcm, hsdM); CamR 19
 
XL10-Gold General cloning host Agilent Technologies 
Cosmids   
Supercos1 Cosmid backbone for S. albus S4 Cos994; CarbR, KanR Stratagene 
Cos994 Supercos1 derivative spanning the surugamide gene cluster from surF into surB; CarbR, KanR This study 
Cos994-ȴsurE Cos994 derivative with surE deletion; CarbR, KanR, AprR This study 
Cos994-ȴsurF Cos994 derivative with surF deletion; CarbR, KanR, AprR This study 
Plasmids   
pDT2 pIJ10257 derivative containing the surE coding sequence 
cloned into the NdeI-HindIII sites; HygR This study 
pET28a Commercial protein production vector, KanR Agilent Technologies 
pET28-surE pET28a derivative containing the surE gene cloned into the NdeI-XhoI restriction sites; KanR  
pIJ773 ReDirect PCR template for the aac(3)IV + oriT cassette 2
 
pIJ10257 pMS81 derivative containing ermE*p, integrates into the ĭBT1 attB site in Streptomyces; HygR 7 
pUZ8002 Encodes the conjugation machinery for mobilisation of plasmids from E. coli to Streptomyces; KanR 19 
Apr, apramycin; Hyg, Hygromycin; Cam, chloramphenicol; Kan, kanamycin; Carb, carbenicillin; oriT, origin of conjugal transfer 
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